Perception Capital Corp. II

Perception Capital Corp. II

PCCT
Perception Capital Corp. IIUS flagNASDAQ Global Market
6.26
USD
-3.09
- -
49.02MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Richard W. Gaenzle Jr.
Sector
Financial Services
Industry
Shell Companies
Address
315 Lake Street East Wayzata MN United States of America 55391
IPO Date
Dec 27, 2021
Business
Perception Capital Corp. II (PCCT) operates as a blank check company, or special purpose acquisition company, with no significant independent operations and focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily in the technology-enabled sector. Incorporated in 2021 and headquartered in Wayzata, Minnesota, the company functions as a subsidiary of Perception Capital Partners II LLC and targets industrial technology opportunities to build long-term value. In October 2023, Perception Capital Corp. II completed a business combination with Spectaire Inc., pursuant to which the merged entity operates as Spectaire Holdings Inc. under the Nasdaq ticker symbols SPEC and SPECW; prior to the transaction, it secured a $3.5 million PIPE commitment from Dr. Jörg Mosolf and additional funding arrangements including a convertible promissory note and warrant issuance. The company maintains a minimal employee base and holds cash reserves in trust for deployment in its targeted acquisition strategy, with institutional ownership reflecting positions by funds and investors. As of late 2025, PCCT shares continue to trade, reflecting post-merger dynamics and market conditions.

Company News

APIChat
  • GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT

  • Spectaire Inc. and Perception Capital Corp. II Complete Business Combination